Fri, March 22, 2013
Thu, March 21, 2013
Wed, March 20, 2013
[ Wed, Mar 20th 2013 ] - Market Wire
From Gloom to Bloom
Tue, March 19, 2013
Mon, March 18, 2013
Sun, March 17, 2013
Sat, March 16, 2013
Fri, March 15, 2013
[ Fri, Mar 15th 2013 ] - Market Wire
Announcement
[ Fri, Mar 15th 2013 ] - Market Wire
First Day of Dealings on ISDX
Thu, March 14, 2013
[ Thu, Mar 14th 2013 ] - Market Wire
Message From the President
Wed, March 13, 2013
[ Wed, Mar 13th 2013 ] - Market Wire
SKTO Announces New Chairman
Tue, March 12, 2013
Mon, March 11, 2013

Marc Grasso Joins Stifel's Healthcare Investment Banking Group


//business-finance.news-articles.net/content/201 .. tifel-s-healthcare-investment-banking-group.html
Published in Business and Finance on by Market Wire   Print publication without navigation


March 18, 2013 16:30 ET

Marc Grasso Joins Stifel's Healthcare Investment Banking Group

ST. LOUIS, MO--(Marketwire - Mar 18, 2013) - Stifel Financial Corp. (NYSE: [ SF ]) today announced that Marc Grasso, M.D. has joined the firm as a Managing Director in its Healthcare Investment Banking Group. Dr. Grasso, who is based in the firm's San Francisco office, will cover biopharmaceutical companies in the U.S.

"Healthcare continues to be an area of strategic importance to our franchise. Marc's addition to the team further solidifies our commitment to this sector, adding to our deep Healthcare Investment Banking platform. With one of the strongest teams in the industry, we are well-positioned to capitalize on the opportunities present in today's environment," commented Brad Raymond, Co-Head of Investment Banking at Stifel.

"We are very pleased that Marc has joined Stifel's Healthcare practice," stated Declan Quirke, Head of Healthcare Investment Banking. "With 15 years of investment banking experience working with companies in the healthcare space, Marc brings strong client relationships in an area where we see significant opportunity for growth."

Most recently, Dr. Grasso was a Managing Director in UBS's Global Healthcare Group, responsible for coverage of biopharmaceutical companies. Before joining UBS in 2010, Dr. Grasso was a Managing Director with Leerink Swann, where he was instrumental in the west coast expansion of their franchise. Dr. Grasso earned a Doctorate in Medicine from Johns Hopkins School of Medicine and an undergraduate degree in Molecular Biology from Princeton University.

Stifel Company Information
Stifel Financial Corp. (NYSE: [ SF ]) is a financial services holding company headquartered in St. Louis, Missouri that conducts its banking, securities, and financial services business through several wholly owned subsidiaries. Stifel clients are served through Stifel, Nicolaus & Company, Incorporated in the U.S., through Stifel Nicolaus Canada Inc. in Canada, through Stifel Nicolaus Europe Limited in the United Kingdom and Europe, and through Keefe, Bruyette & Woods, Inc. in the U.S. and Europe. The Company's broker-dealer affiliates provide securities brokerage, investment banking, trading, investment advisory, and related financial services to individual investors, professional money managers, businesses, and municipalities. Stifel Bank & Trust offers a full range of consumer and commercial lending solutions. Stifel Trust Company, N.A. offers trust and related services. To learn more about Stifel, please visit the Company's web site at [ www.stifel.com ].



Publication Contributing Sources